Literature DB >> 26944187

Self-reported human papillomavirus vaccination does not have an impact on the risk for high-grade cervical intraepithelial neoplasia among women referred for colposcopy.

Lindsay M Kuroki1, Pratibha S Binder2, Matthew A Powell2, L Stewart Massad2, Feng Gao3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26944187      PMCID： PMC5067105          DOI： 10.1016/j.ajog.2016.02.053

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  5 in total

1.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.

Authors: 
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

2.  Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Authors:  J Paavonen; P Naud; J Salmerón; C M Wheeler; S-N Chow; D Apter; H Kitchener; X Castellsague; J C Teixeira; S R Skinner; J Hedrick; U Jaisamrarn; G Limson; S Garland; A Szarewski; B Romanowski; F Y Aoki; T F Schwarz; W A J Poppe; F X Bosch; D Jenkins; K Hardt; T Zahaf; D Descamps; F Struyf; M Lehtinen; G Dubin
Journal:  Lancet       Date:  2009-07-06       Impact factor: 79.321

3.  Comparing Cervical Cytology and Histology Among Human Papillomavirus-Vaccinated and -Unvaccinated Women in an Academic Colposcopy Clinic.

Authors:  Benjamin J Dorton; Allison F Vitonis; Sarah Feldman
Journal:  Obstet Gynecol       Date:  2015-10       Impact factor: 7.661

4.  Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment.

Authors:  Ana Cecilia Rodríguez; Diane Solomon; Rolando Herrero; Allan Hildesheim; Paula González; Sholom Wacholder; Carolina Porras; Silvia Jiménez; Mark Schiffman
Journal:  Am J Epidemiol       Date:  2013-07-10       Impact factor: 4.897

5.  Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.

Authors:  Kevin A Ault
Journal:  Lancet       Date:  2007-06-02       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.